ALBANY, New York, June 11, 2018 /PRNewswire/ --
The global helicobacter pylori (H. pylori) non-invasive testing marketwas valued at approximately US$ 518.0 Mn in 2017 and is projected to register a compounded annual growth rate (CAGR) of over 3.99% from 2018 to 2026, according to a new report titled, "Helicobacter Pylori (H. pylori) Non-invasive
(Logo: https://mma.prnewswire.com/media/664869/Transparency_Market_Research_Logo.jpg )
Read Report Overview: https://www.transparencymarketresearch.com/helicobacter-pylori-non-invasive-testing-market.html
Rise in adoption of non-invasive tests for H. pylori diagnosis globally to fuel the market
There has been a growing preference for non-invasive tests globally for H. pylori infection testing among patients as well as health care providers, owing to quick turnaround time for test results, higher patient compliance, and reduced discomfort usually associated with invasive tests. At the same time, these tests are high in accuracy and specificity to aid the correct diagnosis of the H. pylori infection. Non-invasive tests are also cost-effective compared to invasive endoscopic options.
Serology test segment to lose market share
Among non-invasive tests, serology test is commonly prescribed by health care practitioners for H. pylori owing to the relatively lower cost and ease of conducting of the test. However, the serology test segment is expected to lose its market share during the forecast period. Regional agencies such as American Gastroenterology Association (AGA) and National Health Services (NHS) have updated their guidelines to prevent the use of serology testing for detection of H. pylori due to high incidence rate of false positives, lower specificity as compared to other non-invasive testing methods, and inability to test for eradication of the H. pylori infection in a patient associated with the test. The serology test segment is estimated to hold a market share of 30.3% by the end of 2018, while its market share is anticipated to drop to 13.7% by the end of 2026.
Get PDF Brochure for Research Insights at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=45312
Laboratory-based tests segment to witness significant growth
Among test methods, the laboratory-based tests segment of the global helicobacter pylori (h. pylori) non-invasive testing market is estimated to witness a significant growth during the forecast period. The segment is likely to expand at a CAGR of 3.73% between 2018 and 2026. Growth of the segment can be ascribed to the fact that a majority of these tests are performed in laboratory settings, based on laboratory methods, conducted by trained professionals in a controlled environment. Laboratories are capable of conducting high volume of tests per day and providing the results in a few hours or a few days (1 to 2 days). According to WHO, in Asia Pacific, an estimated 70% of health decisions are based on laboratory results, as laboratory-based tests provide essential support and facilitate appropriate medical intervention.
Request a Custom Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=45312
Diagnostic laboratories to be highly promising among end-users
Among end users, the diagnostic laboratories segment is expected to hold the leading i.e. 47.5% share of the market by 2026. This can be attributed to the large number of H. pylori non-invasive tests performed by standalone and hospital-based diagnostic laboratories. Moreover, presence of major standalone laboratories, testing a large number of patient, and high adoption of new tests and instruments by diagnostic laboratories for diagnosis of H. pylori, is expected to fuel the growth of the diagnostic laboratories segment through 2026.
Asia Pacific to witness significant growth and create high incremental opportunity
The helicobacter pylori (H. pylori) non-invasive testing market in Asia Pacific is estimated to expand at a significant CAGR of 4.52% during the forecast period. The market in the region is likely to be driven by the high prevalence of H. pylori in rural India, (80% or even more), where a vast population is living under poverty and gastric cancer burden, linked to H. pylori bacteria, is relatively high. North America is expected to hold the leading market share of 31.1% by 2026, due to rising incidence of gastric adenocarcinoma, peptic ulcers, and other diseases which are strongly associated with H. pylori infection. This has prompted national and regional health care agencies in the U.S. to actively promote non-invasive diagnostic tests for chronic as well as acute dyspeptic patients, with an aim to eradicate H. pylori infection from among the prevalent population. The helicobacter pylori (H. pylori) non-invasive testing market in North America is likely to register a CAGR of 3.62% during the forecast period.
Request a Sample of Helicobacter Pylori (H. Pylori) Non-invasive Testing Market: https://www.transparencymarketresearch.com/helicobacter-pylori-non-invasive-testing-market.html
Key players to continue leading global helicobacter pylori (H. pylori) non-invasive testing market
Prominent players operating in the global helicobacter pylori (h. pylori) non-invasive testing market are DiaSorin S.p.A., Meridian Bioscience, Inc., Exalenz Bioscience Ltd., Alere, Thermo Fisher Scientific, Biomerica, Inc., Certest Biotec S.L., Sekisui Diagnostics, CorisBioconcept SPRL and Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd. These key players are expected to maintain their key positions during the forecast period.
Popular Research Reports by TMR:
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
Contact Transparency Market Research State Tower, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: email@example.com
Website: http://www.transparencymarketresearch.com Research Blog: https://theglobalhealthnews.com/
SOURCE Transparency Market Research
Subscribe to our Free Newsletters!
Alström syndrome, a rare genetic disorder due to ALMS1 mutations, occurs in the first year of ...
Sodium zirconium cyclosilicate was approved by FDA recently to use as an oral suspension for ...
Encephalocele is a birth defect where a sac like protrusion of brain and covering membranes occurs ...View All